Daily Stock Analysis, CBYL, Carbylan Therapeutics Inc, priceseries

Carbylan Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
0.70
Close
0.68
High
0.72
Low
0.65
Previous Close
0.69
Daily Price Gain
-0.01
YTD High
3.65
YTD High Date
Jan 4, 2016
YTD Low
0.44
YTD Low Date
Oct 4, 2016
YTD Price Change
-2.65
YTD Gain
-79.61%
52 Week High
3.89
52 Week High Date
Dec 28, 2015
52 Week Low
0.44
52 Week Low Date
Oct 4, 2016
52 Week Price Change
-2.14
52 Week Gain
-75.92%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Oct 29. 2015
3.58
Nov 10. 2015
4.25
8 Trading Days
18.80%
Link
LONG
May 16. 2016
0.80
Jun 10. 2016
1.12
18 Trading Days
40.29%
Link
Company Information
Stock Symbol
CBYL
Exchange
NasdaqGM
Company URL
http://www.carbylan.com
Company Phone
650-855-6777
CEO
David M. Renzi
Headquarters
California
Business Address
3181 PORTER DRIVE, PALO ALTO, CA 94304
Sector
-
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0001348911
About

Carbylan Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of novel and proprietary combination therapies.

Description

Carbylan Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of novel and proprietary combination therapies. Its product candidate is Hydros-TA, which is in Phase III clinical trial designed to provide rapid and sustained relief from pain associated with osteoarthritis. The company was formerly known as Carbylan Biosurgery, Inc. and changed its name to Carbylan Therapeutics, Inc. in March 2014. Carbylan BioSurgery, Inc. was founded in 2004 and is headquartered in Palo Alto, California.